Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/6956
Title: Recent advances in the rational design and development of LIM kinase inhibitors are not enough to enter clinical trials
Authors: Manetti, Fabrizio 
Keywords: LIM domain kinases, Inhibitors, Structure-activity relationships, Rational design, Anticancer, Intra-ocular pressure
Issue Date: 2018
Project: None 
Journal: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Description: 
151392
URI: http://hdl.handle.net/20.500.12779/6956
ISSN: 0223-5234
DOI: 10.1016/j.ejmech.2018.06.016
Appears in Collections:Publications

Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.